Cargando…
DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME
INTRODUCTION: Highly Active Antiretroviral Therapy (HAART) has improved and extended the lives of thousands of people living with HIV/AIDS around the world. However, this treatment can lead to the development of adverse reactions such as lipoatrophy/lipohypertrophy syndrome (LLS) and its associated...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435007/ https://www.ncbi.nlm.nih.gov/pubmed/25923888 http://dx.doi.org/10.1590/S0036-46652015000200002 |
_version_ | 1782371834212122624 |
---|---|
author | SOARES, Lismeia Raimundo da SILVA, Daniela Cardeal GONSALEZ, Claudio R. BATISTA, Felipe G. FONSECA, Luiz Augusto M. DUARTE, Alberto J.S. CASSEB, Jorge |
author_facet | SOARES, Lismeia Raimundo da SILVA, Daniela Cardeal GONSALEZ, Claudio R. BATISTA, Felipe G. FONSECA, Luiz Augusto M. DUARTE, Alberto J.S. CASSEB, Jorge |
author_sort | SOARES, Lismeia Raimundo |
collection | PubMed |
description | INTRODUCTION: Highly Active Antiretroviral Therapy (HAART) has improved and extended the lives of thousands of people living with HIV/AIDS around the world. However, this treatment can lead to the development of adverse reactions such as lipoatrophy/lipohypertrophy syndrome (LLS) and its associated risks. OBJECTIVE: This study was designed to assess the prevalence of self-reported lipodystrophy and nutritional status by anthropometric measurements in patients with HIV/AIDS. METHODS: An observational study of 227 adult patients in the Secondary Immunodeficiencies Outpatient Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (3002 ADEE-HCFMUSP). The sample was divided into three groups; Group 1 = 92 patients on HAART and with self-reported lipodystrophy, Group 2 = 70 patients on HAART without self-reported lipodystrophy and Group 3 = 65 patients not taking HAART. The nutritional status of individuals in the study sample was determined by body mass index (BMI) and percentage of body fat (% BF). The cardiovascular risk and diseases associated with abdominal obesity were determined by waist/hip ratio (WHR) and waist circumference (WC). RESULTS: The prevalence of self-reported lipoatrophy/lipohypertrophy syndrome was 33% among women and 59% among men. Anthropometry showed depletion of fat mass in the evaluation of the triceps (TSF) in the treatment groups with HAART and was statistically independent of gender; for men p = 0.001, and for women p = 0.007. Similar results were found in the measurement of skin folds of the upper and lower body (p = 0.001 and p = 0.003 respectively). In assessing the nutritional status of groups by BMI and % BF, excess weight and body fat were more prevalent among women compared to men (p = 0.726). The WHR and WC revealed risks for cardiovascular and other diseases associated with abdominal obesity for women on HAART and with self-reported LLS (p = 0.005) and (p = 0.011). CONCLUSIONS: Anthropometric measurements were useful in the confirmation of the prevalence of LLS. BMI alone does not appear to be a good parameter for assessing the nutritional status of HIV-infected patients on HAART and with LLS. Other anthropometric measurements are needed to evaluate patients with the lipoatrophy/lipohypertrophy syndrome. |
format | Online Article Text |
id | pubmed-4435007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Instituto de Medicina Tropical |
record_format | MEDLINE/PubMed |
spelling | pubmed-44350072015-05-18 DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME SOARES, Lismeia Raimundo da SILVA, Daniela Cardeal GONSALEZ, Claudio R. BATISTA, Felipe G. FONSECA, Luiz Augusto M. DUARTE, Alberto J.S. CASSEB, Jorge Rev Inst Med Trop Sao Paulo HIV INTRODUCTION: Highly Active Antiretroviral Therapy (HAART) has improved and extended the lives of thousands of people living with HIV/AIDS around the world. However, this treatment can lead to the development of adverse reactions such as lipoatrophy/lipohypertrophy syndrome (LLS) and its associated risks. OBJECTIVE: This study was designed to assess the prevalence of self-reported lipodystrophy and nutritional status by anthropometric measurements in patients with HIV/AIDS. METHODS: An observational study of 227 adult patients in the Secondary Immunodeficiencies Outpatient Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (3002 ADEE-HCFMUSP). The sample was divided into three groups; Group 1 = 92 patients on HAART and with self-reported lipodystrophy, Group 2 = 70 patients on HAART without self-reported lipodystrophy and Group 3 = 65 patients not taking HAART. The nutritional status of individuals in the study sample was determined by body mass index (BMI) and percentage of body fat (% BF). The cardiovascular risk and diseases associated with abdominal obesity were determined by waist/hip ratio (WHR) and waist circumference (WC). RESULTS: The prevalence of self-reported lipoatrophy/lipohypertrophy syndrome was 33% among women and 59% among men. Anthropometry showed depletion of fat mass in the evaluation of the triceps (TSF) in the treatment groups with HAART and was statistically independent of gender; for men p = 0.001, and for women p = 0.007. Similar results were found in the measurement of skin folds of the upper and lower body (p = 0.001 and p = 0.003 respectively). In assessing the nutritional status of groups by BMI and % BF, excess weight and body fat were more prevalent among women compared to men (p = 0.726). The WHR and WC revealed risks for cardiovascular and other diseases associated with abdominal obesity for women on HAART and with self-reported LLS (p = 0.005) and (p = 0.011). CONCLUSIONS: Anthropometric measurements were useful in the confirmation of the prevalence of LLS. BMI alone does not appear to be a good parameter for assessing the nutritional status of HIV-infected patients on HAART and with LLS. Other anthropometric measurements are needed to evaluate patients with the lipoatrophy/lipohypertrophy syndrome. Instituto de Medicina Tropical 2015 /pmc/articles/PMC4435007/ /pubmed/25923888 http://dx.doi.org/10.1590/S0036-46652015000200002 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | HIV SOARES, Lismeia Raimundo da SILVA, Daniela Cardeal GONSALEZ, Claudio R. BATISTA, Felipe G. FONSECA, Luiz Augusto M. DUARTE, Alberto J.S. CASSEB, Jorge DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME |
title | DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG
HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH
LIPOATROPHY/LIPOHYPERTROPHY SYNDROME |
title_full | DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG
HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH
LIPOATROPHY/LIPOHYPERTROPHY SYNDROME |
title_fullStr | DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG
HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH
LIPOATROPHY/LIPOHYPERTROPHY SYNDROME |
title_full_unstemmed | DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG
HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH
LIPOATROPHY/LIPOHYPERTROPHY SYNDROME |
title_short | DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG
HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH
LIPOATROPHY/LIPOHYPERTROPHY SYNDROME |
title_sort | discordance between body mass index and anthropometric measurements among
hiv-1-infected patients on antiretroviral therapy and with
lipoatrophy/lipohypertrophy syndrome |
topic | HIV |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435007/ https://www.ncbi.nlm.nih.gov/pubmed/25923888 http://dx.doi.org/10.1590/S0036-46652015000200002 |
work_keys_str_mv | AT soareslismeiaraimundo discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome AT dasilvadanielacardeal discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome AT gonsalezclaudior discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome AT batistafelipeg discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome AT fonsecaluizaugustom discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome AT duartealbertojs discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome AT cassebjorge discordancebetweenbodymassindexandanthropometricmeasurementsamonghiv1infectedpatientsonantiretroviraltherapyandwithlipoatrophylipohypertrophysyndrome |